1910 Genetics
MA - BostonBiotechnology
Focus: 1910 Genetics is a computational chemistry biotech platform company focused on developing small molecule therapeutics across ophthalmology, neurology, and gastroenterology. The company operates as a pre-revenue or early-stage biotech with a technology-first approach to drug discovery.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Open Jobs
6
Should You Work at 1910 Genetics?
AI assessmentBest suited for technologists and platform builders who thrive in early-stage computational environments; traditional pharma career progressors should wait for clinical validation.
Why Work Here
- Join a computational-first platform company during formation, offering opportunity to shape drug discovery methodology in an emerging biotech
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for 1910 Genetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.